INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Brain & Mood desk →

1,209 studies · page 36 of 51

2009 / Narrative review

Positive affect is associated with healthier behaviors and favorable biological markers like lower cortisol and reduced inflammatory indicators.

This review examines behavioral and biological processes linking positive psychological states with health outcomes such as reduced cardiovascular disease risk and infection resistance. Evidence linking positive affect with health behaviors has been mixed, though recent cross-cultural work documented associations with regular exercise, not smoking, and prudent diet. Biologically, positive affect has been consistently linked to lower cortisol output, as well as favorable associations with heart rate, blood pressure, and interleukin-6, independent of negative affect.

Shows an association, not proof of cause and effect.

Steptoe A, Dockray S, Wardle J J Pers, 2009. PMID 19796062

2009 / Narrative review / hypothesis paper

Cyanobacterial BMAA bioaccumulates in food chains and is detected in brains of patients with ALS, Alzheimer's disease, and Guamanian ALS/PDC.

This review discusses the hypothesis that the neurotoxin beta-methylamino-L-alanine (BMAA), produced by cyanobacteria, may contribute to ALS and other neurodegenerative diseases. Protein-bound BMAA was identified in brains of Guamanians dying of ALS/PDC (average 627 microg/g, 5 mM) and North American Alzheimer's disease patients (average 95 microg/g, 0.8 mM), but not in controls. Although Montine et al. failed to replicate these findings using different methods, subsequent work confirmed protein-bound BMAA (>100 microg/g) in brains of North American patients dying with ALS and Alzheimer's disease.

Shows an association, not proof of cause and effect.

Bradley WG, Mash DC Amyotroph Lateral Scler, 2009. PMID 19929726

2009 / Narrative review

Shift work with night shifts negatively affects sleep, performance, accident risk, and health outcomes such as cardiovascular disease and certain cancers.

This review discusses the prevalence and impacts of shift work involving night work. Night shifts negatively affect sleep, sleepiness, performance, accident risk, and health outcomes like cardiovascular disease and specific cancers due to circadian misalignment. Shifts longer than 12 hours and individual vulnerability increase risks, and while some countermeasures can mitigate nighttime sleepiness and daytime insomnia, current approaches cannot eliminate most negative physiological and cognitive effects.

Akerstedt T, Wright KP Sleep Med Clin, 2009. PMID 20640236

2008 / Narrative review

Curcumin is safe up to 12 g daily for 3 months in phase I trials and may have potential therapeutic roles across various chronic diseases.

This review summarizes research on curcumin, the active compound in turmeric. Preclinical studies suggest curcumin has antiproliferative, chemopreventive, and therapeutic potential across diverse conditions by modulating kinases, transcription factors, and cell cycle proteins. Pilot phase I clinical trials have shown curcumin to be safe even when consumed at a daily dose of 12 g for 3 months. Other clinical trials suggest a potential therapeutic role for curcumin in diseases including familial adenomatous polyposis, inflammatory bowel disease, ulcerative colitis, colon cancer, pancreatic cancer, hypercholesteremia, atherosclerosis, pancreatitis, psoriasis, chronic anterior uveitis, and arthritis.

Goel A, Kunnumakkara AB, Aggarwal BB Biochem Pharmacol, 2008. PMID 17900536

2008 / Narrative review

Lead exposure below 10 µg/dL is associated with neurodevelopmental deficits such as reduced IQ and academic problems in children.

This review evaluated evidence regarding children's neurodevelopmental outcomes at blood lead levels below 10 microg/dl. Adverse outcomes, including reduced intelligence quotient and academic deficits, occur below 10 microg/dl, and some studies suggest the rate of performance decline is greater below this threshold than above it. Increased exposure is also linked to neuropsychiatric disorders like attention deficit hyperactivity disorder and antisocial behavior. Current chelation protocols appear ineffective for preventing these effects, while environmental enrichment might help.

Shows an association, not proof of cause and effect.

Bellinger DC Curr Opin Pediatr, 2008. PMID 18332714

2008 / Narrative review

Evidence suggests prenatal fish intake offers benefits, but methylmercury exposure from maternal fish consumption is linked to mild detrimental neurocognitive effects.

This review summarizes evidence on early life mercury exposure from maternal fish intake, thimerosal in vaccines, and dental amalgam in relation to child neurodevelopment. Recent studies show mild detrimental neurocognitive effects from prenatal methylmercury exposure, while also suggesting benefits from prenatal fish consumption. The authors note that high-mercury fish should be avoided, but interventions reducing low-level mercury exposure must consider potential harms from reduced docosahexaenoic acid intake if seafood consumption decreases.

Shows an association, not proof of cause and effect.

NANO counterpoint →

Oken E, Bellinger DC Curr Opin Pediatr, 2008. PMID 18332715

2008 / Narrative review

A review identifies 10 neurophysiological pathways that can promote automatic and subconscious food choices, contributing to obesity.

This narrative review examines how the modern food environment stimulates automatic reflexive responses that increase caloric intake and desire to eat. The author identifies 10 neurophysiological pathways driving food choices below individual awareness, such as uncontrollable neurohormonal responses to food images and smells, mirror neurons prompting imitation of eating behaviors, and limited cognitive capacity. Based on these pathways, the article concludes that societal regulation of food cues, portion sizes, availability, and advertising is necessary.

Cohen DA Diabetes, 2008. PMID 18586908

2008 / Narrative review

Scientists disagree regarding the safety of artificial sweeteners and their potential links to cancers, neurological disorders, and glucose regulation.

This review examines the safety and potential toxicity of artificial sweeteners, which provide sweetness without calories. While potentially beneficial for those who cannot tolerate sugar, such as individuals with diabetes, scientific disagreement persists regarding their relationships with lymphomas, leukemias, cancers of the bladder and brain, chronic fatigue syndrome, Parkinson's disease, Alzheimer's disease, multiple sclerosis, autism, and systemic lupus. The article reviews the chemical structure, biological fate, physiological effects (including impacts on glucose regulation), and animal and human studies alongside current regulations.

Whitehouse CR, Boullata J, McCauley LA AAOHN J, 2008. PMID 18604921

2008 / Narrative review

Lacunar infarcts carry long-term risks of stroke recurrence, cognitive decline, dementia, and death, requiring lifestyle and medical secondary prevention.

This review discusses lacunar infarcts, which account for approximately one quarter of all ischaemic strokes. Recent studies indicate the prognosis is not benign, showing recurrent stroke risks comparable to other ischaemic stroke subtypes alongside increased long-term risks for cognitive decline, dementia, and death. Key elements identified for secondary prevention include antiplatelet drugs, careful blood pressure control, statins, and modification of lifestyle risk factors.

Norrving B Pract Neurol, 2008. PMID 18644908

2008 / Systematic review of case reports

A review of 76 cases linked traditional medicine use to lead encephalopathy, predominantly affecting infants and young children with high rates of harm.

Researchers conducted a systematic literature search across multiple databases from 1966 to February 2007 for case reports of human lead encephalopathy associated with traditional medical practices. They identified 76 cases: 66 (87%) linked to Middle Eastern remedies, 5 (7%) to Ayurvedic medicines, and 5 (7%) to other remedies. Overall, 95% of cases were in infants and young children and 5% in adults. Among the 72 pediatric cases, 8 (11%) were fatal and at least 15 (21%) had residual neurological deficits, while at least one of the 4 adult cases had residual neurological impairment.

Shows an association, not proof of cause and effect.

Karri SK, Saper RB, Kales SN Curr Drug Saf, 2008. PMID 18690981

2008 / Narrative review

Atypical parkinsonism in Guadeloupe was linked to regular soursop consumption, with annonacin implicated as a potential etiological factor.

In Guadeloupe, atypical parkinsonian patients comprise two-thirds of all parkinsonism cases, presenting with levodopa-resistant parkinsonism, tremor, myoclonus, hallucinations, REM sleep behavior disorder, and fronto-subcortical dementia. Epidemiological data suggested a close association between the condition and regular consumption of soursop. Experimental midbrain cell culture studies identified annonacin, a mitochondrial complex I inhibitor in soursop, as a probable etiological factor, and chronic annonacin administration reproduced characteristic brain lesions in rats.

Shows an association, not proof of cause and effect.

Lannuzel A, Ruberg M, Michel PP Mov Disord, 2008. PMID 18816693

2008 / Historical review

A historical review traces the origins, decline, and recent resurgence of the ketogenic diet as a treatment for childhood epilepsy.

This narrative review outlines the historical use of fasting and dietary regimens to treat epilepsy since at least 500 BC. The ketogenic diet was developed in the 1920s to mimic fasting metabolism and was widely utilized for two decades before declining with the advent of antiepileptic drugs. The author notes that after being limited to a few children's hospitals by the late twentieth century, scientific interest and clinical use of the diet have experienced an explosion over the past 15 years.

Wheless JW Epilepsia, 2008. PMID 19049574

2008 / Narrative review / clinical practice overview

Ketogenic diet therapy for pediatric epilepsy requires structured medical nutrition therapy including assessment, diet therapy, and follow-up care.

The ketogenic diet serves as a medical nutrition therapy (MNT) for treating epilepsy, influencing an individual's health and chronic condition. The authors outline their clinical approach to ketogenic diet therapy in a pediatric population based on American Dietetic Association core MNT guidelines—consisting of a diet history, assessment, diet therapy, and a follow-up care plan. Much of the described management strategy is derived from practical clinical experience.

Zupec-Kania B, Zupanc ML Epilepsia, 2008. PMID 19049580

2007 / Narrative review

Dietary calcium supplementation in pregnancy and lactation is associated with reductions in maternal lead levels in both animal and human studies.

Pregnancy and lactation increase bone resorption to meet fetal and infant calcium demands, potentially mobilizing maternal bone lead stores into the circulation. Since over 95% of maternal lead is stored in bone, this mobilization acts as an endogenous exposure hazard for fetal neurodevelopment and growth. Maternal dietary calcium supplementation has been associated with reductions in lead levels during pregnancy and lactation in animal and human studies, suggesting it may serve as a secondary prevention strategy.

Ettinger AS, Hu H, Hernandez-Avila M J Nutr Biochem, 2007. PMID 17296490

2007 / Narrative review

A review outlines the mechanisms of jet lag and examines pharmacological and behavioural coping strategies to adjust the body clock.

This review examines travel fatigue and jet lag associated with the increasing number of long-distance flights. It discusses symptoms related to sleep loss and decreased performance, properties of the body clock, and methods for adjusting it in a new time zone. Pharmacological and behavioural strategies used to alleviate the negative results of time-zone transitions are reviewed to provide advice for travellers, alongside unresolved problems in the field.

Waterhouse J, Reilly T, Atkinson G, et al. Lancet, 2007. PMID 17398311

2007 / Narrative review

Nutrient supplementation with essential elements and vitamins may help abate some toxic effects of environmental lead exposure.

Environmental lead toxicity remains a persistent global public health issue, with children being particularly susceptible and vulnerable to effects on intellectual development. Conventional chelating agents lack adequate safety and efficacy. This review discusses sources of lead exposure, current blood lead levels, and evidence suggesting that nutrient supplementation with essential elements and vitamins may play an important role in mitigating lead's toxic effects.

Ahamed M, Siddiqui MK Clin Nutr, 2007. PMID 17499891

2007 / Consensus conference and literature review

An expert consensus recommends pregnant and lactating women consume at least 200 mg DHA daily, including one to two portions of sea fish per week.

The PERILIP project, with the Early Nutrition Programming Project, performed literature reviews and held a consensus conference to develop recommendations on dietary fat intake during pregnancy and lactation. The panel concluded that total fat intake should align with general population guidelines and recommended an average intake of at least 200 mg DHA/d. Women of childbearing age should aim for one to two portions of sea fish weekly, including oily fish, noting that preformed DHA is far more effective for fetal brain deposition than alpha-linolenic acid. Intakes up to 1 g/d DHA or 2.7 g/d n-3 long-chain PUFA were noted as used in trials without significant adverse effects, and long-chain n-3 fatty acid intake resulted in slightly longer pregnancy duration.

NANO counterpoint →

Koletzko B, Cetin I, Brenna JT, et al. Br J Nutr, 2007. PMID 17688705

2007 / Narrative review

Curcumin is safe up to 12 g/day in humans but exhibits poor bioavailability due to poor absorption, rapid metabolism, and rapid systemic elimination.

This review examines the bioavailability and pharmacologic properties of curcumin, a polyphenol derived from turmeric. Phase I clinical trials demonstrate that curcumin is safe even at high doses up to 12 g/day in humans, but it has poor bioavailability driven by poor absorption, rapid metabolism, and rapid systemic elimination. Approaches to enhance bioavailability include adjuvants like piperine, liposomal curcumin, nanoparticles, phospholipid complexes, and structural analogues such as EF-24. Despite low bioavailability, therapeutic efficacy has been documented against human diseases including cancer, cardiovascular diseases, diabetes, arthritis, neurological diseases, and Crohn's disease.

Anand P, Kunnumakkara AB, Newman RA, et al. Mol Pharm, 2007. PMID 17999464

2007 / Narrative review

Seychelles data through age 9 showed no consistent adverse link between prenatal methyl mercury from fish and child neurodevelopment.

This review examines nutrients in fish essential for brain growth alongside risks of methyl mercury (MeHg) exposure, focusing on the Seychelles Child Development Study where fish is consumed daily. In the Seychelles cohort, evaluations of children through 9 years of age revealed no consistent pattern of adverse associations with prenatal MeHg exposure. Recent research has evaluated nutrients like long-chain polyunsaturated fatty acids, iodine, iron, and choline. Preliminary findings suggest that beneficial nutrients from fish might counter adverse effects of MeHg on the developing nervous system.

Shows an association, not proof of cause and effect.

NANO counterpoint →

Myers GJ, Davidson PW, Strain JJ J Nutr, 2007. PMID 18029503

2007 / Narrative review

Extended-duration work shifts are linked to increased fatigue and impaired performance and safety among nurses and physicians-in-training.

A review examined evidence on health care provider work hours, sleep deprivation, safety, and performance. Nurses working shifts greater than 12.5 hours are at significantly increased risk of decreased vigilance, occupational injury, or making a medical error. Physicians-in-training working traditional > 24-hour on-call shifts face increased risks of occupational sharps injuries, motor vehicle crashes, and serious or fatal medical errors. Compared to 16-hour shifts, on-call residents working overnight have twice as many attentional failures, commit 36% more serious medical errors, and report 300% more fatigue-related medical errors leading to a patient's death.

Shows an association, not proof of cause and effect.

Lockley SW, Barger LK, Ayas NT, et al. Jt Comm J Qual Patient Saf, 2007. PMID 18173162

2006 / Narrative review

Inhibition of MAO by tobacco constituents enhances addiction from smoking, and MAO reduction in alcoholics likely stems from concurrent tobacco use.

This review examines PET-scan and neurochemical data on monoamine oxidase (MAO) inhibition related to tobacco and alcohol use. PET-scan studies indicate that brain MAO activity decreases in tobacco smokers and reverts to control levels upon quitting, likely due to MAO-inhibiting tobacco constituents. A similar reversible decrease in MAO activity reported in Type II alcoholism is probably attributable to concurrent tobacco use. The authors conclude that MAO inhibition by tobacco and smoke constituents enhances tobacco addiction.

van Amsterdam J, Talhout R, Vleeming W, et al. Life Sci, 2006. PMID 16884739

2006 / Clinical recommendations / narrative review

The American Thyroid Association recommends 150 µg daily iodine supplementation for women during pregnancy and lactation.

Maternal dietary iodine is essential for thyroxine production and normal fetal brain development, with insufficiency potentially causing irreversible fetal brain damage. In 2001-2002, US median urinary iodine was 168 µg/L, and pregnant women had a median of 173 µg/L (95% CI 75-229 µg/L), though the lower 95% CI fell below the WHO-recommended 150 µg/L threshold. Consequently, the American Thyroid Association recommends women take a 150 µg iodine supplement daily during pregnancy and lactation and that all prenatal vitamins contain 150 µg of iodine.

Public Health Committee of the American Thyroid Association, Becker DV, Braverman LE, et al. Thyroid, 2006. PMID 17042677

2005 / Historical article and interviews

A historical review details the Minnesota Starvation Experiment, where semistarvation led to >25% weight loss, anemia, fatigue, and neurological deficits.

During World War II, Ancel Keys and colleagues subjected 36 conscientious objectors to a grueling semistarvation study to evaluate the physical and psychologic effects of starvation and refeeding. Most participants lost >25% of their weight, and many experienced anemia, fatigue, apathy, extreme weakness, irritability, neurological deficits, and lower extremity edema. In 2003-2004, 18 surviving participants were interviewed; all expressed strong convictions about nonviolence, and the men were unanimous in stating they would participate again despite their suffering.

Kalm LM, Semba RD J Nutr, 2005. PMID 15930436

2005 / Narrative review

Controlled studies showing that chelation therapy improves outcomes for putative mercury poisoning are lacking.

Public awareness of mercury's potential health problems has grown, but there is also an increasing tendency to attribute unexplained neurological and other symptoms to mercury without confirmed significant exposure. Diagnosing mercury intoxication remains challenging because signs overlap with other causes such as undiagnosed neurological disorders, medication effects, vitamin or mineral deficiencies, or stress. Controlled studies demonstrating that chelation therapy improves patient outcomes are lacking, and physicians should communicate the risks of chelating drugs before treatment.

Risher JF, Amler SN Neurotoxicology, 2005. PMID 16009427